NCT07205783

Brief Summary

In the last few decades not only the diagnosis but also the treatment options for prostate cancer have changed significantly. During this time the surgical procedure of open radical prostatectomy was substantially modified(1,2) and is nowadays considered a safe procedure providing high cancer control rates with low morbidity.(3) The main goal of radical prostatectomy regardless of the approach remains the eradication of cancer while preserving pelvic organ function,whenever possible.(4)

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
8mo left

Started Sep 2025

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2025Jan 2027

Study Start

First participant enrolled

September 14, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 26, 2025

Last Update Submit

September 26, 2025

Conditions

Keywords

open radical prostatectomy prostate cancer

Outcome Measures

Primary Outcomes (1)

  • tumor control

    percentage of tumor recurrence

    6 months

Study Arms (1)

cancer prostate

EXPERIMENTAL
Procedure: open radical prostatectomy

Interventions

open surgery to remove prostate gland and the tumor

cancer prostate

Eligibility Criteria

Age40 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cancer prostate: confirmed by prostate biopsy Cancer stage: T2,T3

You may not qualify if:

  • coagulopathy. Pulmonary diseases metastatic tumor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, Sohag Governorate, 82511, Egypt

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 3, 2025

Study Start

September 14, 2025

Primary Completion (Estimated)

September 14, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations